{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:03:53Z","timestamp":1791255833634,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.autrev.2016.02.021","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T17:39:31Z","timestamp":1456681171000},"page":"664-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Modified immunotherapy for alopecia areata"],"prefix":"10.1016","volume":"15","author":[{"given":"Takashi","family":"Yoshimasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukumi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.02.021_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2005.07.001","article-title":"Alopecia areata: a tissue specific autoimmune disease of the hair follicle","volume":"5","author":"Gilhar","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.02.021_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2016.02.021_bb0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists' guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0020","first-page":"1841","article-title":"The Japanese Dermatological Association's guidelines for the management of alopecia areata 2010","volume":"120","author":"Arase","year":"2010","journal-title":"Jpn J Dermatol B"},{"key":"10.1016\/j.autrev.2016.02.021_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.02.021_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/jidsymp.2015.31","article-title":"Toward the clonotype analysis of alopecia areata-specific, intralesional human CD8+ T lymphocytes","volume":"17","author":"Bertolini","year":"2015","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2016.02.021_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1523-1747.1999.00640.x","article-title":"Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H\/HeJ mice","volume":"113","author":"Freyschmidt-Paul","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000350933","article-title":"Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles","volume":"226","author":"Tanemura","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2016.02.021_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000353159","article-title":"Comparison of interleukin-17- producing cells in different clinical types of alopecia areata","volume":"227","author":"Tojo","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2016.02.021_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients","volume":"42","author":"Avitabile","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasy\u0142yszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2016.02.021_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4103\/0378-6323.116725","article-title":"Alopecia areata: an update","volume":"79","author":"Seetharam","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"7","key":"10.1016\/j.autrev.2016.02.021_bb0065","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/archderm.1978.01640190024007","article-title":"Treatment of alopecia areata with dinitrochlorobenzene","volume":"114","author":"Daman","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-1218(96)90099-3","article-title":"Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts","volume":"371","author":"DeLeve","year":"1996","journal-title":"Mutat Res"},{"key":"10.1016\/j.autrev.2016.02.021_bb0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-4362.1996.tb01618.x","article-title":"Treatment of alopecia areata with squaric acid dibutylester","volume":"35","author":"Micali","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","article-title":"Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis","volume":"35","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0090","article-title":"Retrospective review of diphencyprone in the treatment of alopecia areata","author":"Lamb","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0095","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0974-7753.90816","article-title":"Practicality in using diphenyl cyclo propenone for alopecia areata","volume":"3","author":"Muthuvel","year":"2011","journal-title":"Int J Trichol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0733-8635(18)30255-9","article-title":"Topical immunotherapy of alopecia areata","volume":"11","author":"van der Steen","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.autrev.2016.02.021_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630410023601","article-title":"Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial","volume":"16","author":"Dall'oglio","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.autrev.2016.02.021_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2001.04399.x","article-title":"The therapeutic use of topical contact sensitizers in benign dermatoses","volume":"145","author":"Buckley","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(84)80091-2","article-title":"Topical therapy of alopecia areata with squaric acid dibutylester","volume":"10","author":"Case","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clindermatol.2014.12.001","article-title":"Treatment of alopecia areata with squaric acid dibutylester","volume":"33","author":"Hill","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/jidsymp.2015.28","article-title":"Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"17","author":"Chiang","year":"2015","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.autrev.2016.02.021_bb0135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1346-8138.2010.00903.x","article-title":"Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata","volume":"37","author":"Inui","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/1346-8138.12376","article-title":"Hapten-induced lymphadenosis benigna cutis secondary to squaric acid dibutylester sensitization for alopecia areata","volume":"41","author":"Adachi","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jaad.2009.11.681","article-title":"Cutaneous lymphoid hyperplasia related to squaric acid dibutyl ester","volume":"65","author":"Millican","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0150","first-page":"1394","article-title":"Low-dose diphenylcyclopropenone treatment in alopecia areata abstract","volume":"133","author":"Kim","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2015.04.064","article-title":"Squaric acid sensitization is not required for response in the treatment of alopecia areata","volume":"73","author":"Vedak","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.02.021_bb0160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Oslen","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.02.021_bb0165","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2016.02.021_bb0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1346-8138.12938","article-title":"Contact immunotherapy-resistant alopecia areata totalis\/universalis reactive to topical corticosteroid","volume":"42","author":"Inui","year":"2015","journal-title":"J Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T02:43:07Z","timestamp":1567651387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1568997216300489"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified immunotherapy for alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}